Recent literature focuses attention on new roles for tumor protein p53 (TP53) beyond cancer progression, in processes such as metabolic syndrome, insulin resistance, adipose tissue inflammation, obesity, and skeletal muscle differentiation and homeostasis [5, 6]. This evidence concerns the gene TP53 and obesity due to melanocortin 4 receptor deficiency.